Apricoxib

Apricoxib

Systematic (IUPAC) name
4-[2-(4-Ethoxyphenyl)-4-methyl-1H-pyrrol-1-yl]benzenesulfonamide
Clinical data
Identifiers
CAS Registry Number	162011-90-7
PubChem	CID 9820073
ChemSpider	7995822
Chemical data
Formula	C19H20N2O3S
Molecular mass	356.4387 g/mol
SMILES CCOC1=CC=C(C=C1)C2=CC(=CN2C3=CC=C(C=C3)S(=O)(=O)N)C

Apricoxib is an experimental anticancer drug in Phase II clinical trials. It is a COX-2 inhibitor which improves standard therapy response in molecularly defined models of pancreatic cancer.^[1]

See also

• Tilmacoxib
• cimicoxib
• NS-398
• Celecoxib

References